Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04839978 · ClinicalTrials.gov registry record · NA
Community Trial in the Cherokee Nation
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 919
- Enrollment target
NCT04839978: Completed NA study, sponsored by Emory University.
NCT04839978 is a NA study that has completed, run by Emory University. The registered enrollment target is 919 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04839978, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 919 participants
- Enrollment target
Study Summary
The target population is students attending high schools in small rural towns in the 14 counties that partially or fully fall within the Cherokee Nation reservation. Following recruitment of 20 school-based clusters, clusters are allocated to either the intervention condition or delayed-intervention control condition using constrained randomization. Constrained randomization helps to ensure balanced cluster sizes as well as similar levels of risk between the intervention and control at baseline. Study participants include all 10th grade students enrolled in the participating study high schools and students will be followed into the first year after their expected graduation.
Primary Outcome
The number of days of alcohol use in the past 30 days is compared between study arms.
Interventions
- BEHAVIORAL Connect Program
- BEHAVIORAL Communities Mobilizing for Change and Action (CMCA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 919 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT04839978 record still lists
NCT04839978 is an interventional study that assigns participants to a tested intervention. The registered 919 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% lower).
The record links to 0 conditions, and to 2 interventions - of which Connect Program is the first listed.
NCT04839978 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04839978 about?
NCT04839978 is a clinical study titled "Community Trial in the Cherokee Nation". The target population is students attending high schools in small rural towns in the 14 counties that partially or fully fall within the Cherokee Nation reservation. Following recruitment of 20 school-based clusters, clusters are allocated to either the intervention condition or delayed-intervention...
What is the current status of trial NCT04839978?
This trial is currently completed. It is a NA study. The enrollment target is 919 participants. The study started on 2021-09-29. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT04839978?
The interventions under investigation include: Connect Program (BEHAVIORAL), Communities Mobilizing for Change and Action (CMCA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04839978?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04839978's enrollment target sits among peer trials
919 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04589845 · 920 participants · Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- NCT06109870 · 920 participants · NA
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
- NCT06957366 · 920 participants · NA
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
- NCT07174336 · 920 participants · Phase 3
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI